Your browser doesn't support javascript.
loading
Qiyu Sanlong Decoction enhances Th1 immune response through PD-1 signaling pathway and inhibits metastasis of lung cancer / 安徽医科大学学报
Article in Zh | WPRIM | ID: wpr-1038885
Responsible library: WPRO
ABSTRACT
Objective @#To investigate the effect of Qiyu Sanlong Decoction ( QYSLD) on inhibiting lung cancer by regulating tumor immune microenvironment through PD-1 signaling pathway and on Th1 immune response in lung cancer bearing mice.@*Methods @#Lewis lung cancer cell line ( LLC) was used to model subcutaneously implanted tumor in mice.72 mice were randomly divided into Control group ( n = 18 ) ,cisplatin group ( n = 18 ) ,QYSLD group (n = 18) and combined group (n = 18) .The general survival of mice was observedand recorded ; the specific Th1 cell response to tumor antigen was detected by ELISA method ; the proportion of PD-1 positive cells and the ap- optosis of memory CD4 + T cells in spleen T cells of mice were detected by flow cytometry ; and the number and vol- ume of pulmonary metastatic nodules were counted under an anatomical microscope after 21 days of continuous treatment. @*Results @#QYSLD could improve the general survival of mice bearing lung cancer,up-regulate the im- mune response of CD4 + T cells and the specific killing effect of CD8 + T cells.The proportion of apoptotic cells in PD-1 positive cells and CD4 + memory T cells in spleen T cells of mice was down-regulated,and lung metastasis of mouse tumor cells was inhibited.@*Conclusion @#QYSLD can improve the survival status of mice bearing lung cancer and enhance Th1 immune response by mediating PD-1 signaling pathway,improve immune function and inhibit im- mune escape of tumor cells,thus inhibiting the metastasis of lung cancer.
Key words
Search on Google
Database: WPRIM Language: Zh Journal: Acta Universitatis Medicinalis Anhui Year: 2022 Document type: Article
Search on Google
Database: WPRIM Language: Zh Journal: Acta Universitatis Medicinalis Anhui Year: 2022 Document type: Article